DaVita Price Target Raised to $150.00/Share From $139.00 by TD Cowen
DaVita Analyst Ratings
TD Cowen Maintains Hold on DaVita, Raises Price Target to $150
TD Cowen Initiates DaVita(DVA.US) With Hold Rating, Announces Target Price $150
Balanced Outlook: Hold Rating on DaVita Amid Valuation and Regulatory Uncertainties
TD Cowen Reaffirms Their Hold Rating on DaVita (DVA)
DaVita (DVA) Receives a Hold From Barclays
DaVita Analyst Ratings
Truist Financial Keeps Their Hold Rating on DaVita (DVA)
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating
TD Cowen Adjusts Price Target on DaVita to $139 From $136
DaVita Analyst Ratings
Barclays Adjusts Price Target on DaVita to $150 From $133
Barclays Keeps Their Hold Rating on DaVita (DVA)
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and DaVita (DVA)
Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating
DaVita Analyst Ratings
TD Cowen Sticks to Their Hold Rating for DaVita (DVA)
DaVita Analyst Ratings
DaVita Analyst Ratings
No Data